Tolerance and Efficacy of Combined Nivolumab and Ipilimumab Following Monotherapy with PD-1 or CTLA-4 Blockade in Metastatic Melanoma

S Randhawa, Bella Hai Nguyen, Sayed Ali, Desmond Yip

Research output: Contribution to journal › Literature review

Original language	English
Pages (from-to)	71-71
Journal	Asia-Pacific Journal of Clinical Oncology
Issue number	Special Issue, Supplement 2
Publication status	Published - 2017

Cite this

@article{bd50ac93058b4d3ea6981409b84853b8,

title = "Tolerance and Efficacy of Combined Nivolumab and Ipilimumab Following Monotherapy with PD-1 or CTLA-4 Blockade in Metastatic Melanoma",

author = "S Randhawa and Nguyen, {Bella Hai} and Sayed Ali and Desmond Yip",

year = "2017",

language = "English",

pages = "71--71",

journal = "Asia-Pacific Journal of Clinical Oncology",

publisher = "Blackwell Pub. Asia",

number = "Special Issue, Supplement 2",

}

TY - JOUR

T1 - Tolerance and Efficacy of Combined Nivolumab and Ipilimumab Following Monotherapy with PD-1 or CTLA-4 Blockade in Metastatic Melanoma

AU - Randhawa, S

AU - Nguyen, Bella Hai

AU - Ali, Sayed

AU - Yip, Desmond

PY - 2017

Y1 - 2017

M3 - Literature review

SP - 71

EP - 71

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

IS - Special Issue, Supplement 2

ER -